Auna initiated with a Buy at HSBC

HSBC initiated coverage of Auna with a Buy rating and $12.60 price target. Auna has built a unique business model in the industry, led by its focus on select, high complexity procedures, including oncology, traumatology, orthopedics, and cardiology, the analyst tells investors in a research note. The firm says the company has “impressive” secular growth with a proven track record, and short-term growth opportunities at a “compelling valuation.”